Related by context. All words. (Click for frequent words.) 69 commercializing therapeutic 69 rheumatoid arthritis psoriasis 68 inflammatory autoimmune 68 cardiovascular gastrointestinal 68 inflammatory autoimmune diseases 67 CNS disorders 67 anti infectives cardiovascular 67 autoimmune diseases inflammation 67 rheumatoid arthritis thrombocytopenia 66 endocrine diseases 66 kidney urologic 66 neuropathic pain metabolic diseases 66 immuno inflammatory diseases 66 fibrotic diseases 65 immunological diseases 65 immunologic diseases 65 inflammation metabolic disorders 65 Parkinson disease monogenic diseases 65 POSIDUR TM ELADUR TM 65 oncology infectious diseases 65 respiratory gastrointestinal 64 gastro intestinal inflammation 64 purinergic receptors P#X# 64 inflammatory disorders 64 renal diseases 64 therapeutic anticancer 64 oncology metabolic disorders 64 ophthalmology oncology 64 oncology endocrinology 64 dermatological disorders 64 oncology immunology 64 skeletal muscle weakness 64 REMOXY ® 64 gastroenterology neurology 64 autologous cellular therapies 64 rheumatoid arthritis multiple sclerosis 64 psoriasis rheumatoid arthritis 64 cardio metabolic diseases 64 autoimmune inflammatory 64 oncology cardiology 64 Provectus Pharmaceuticals specializes 64 neurology oncology 64 Parkinson disease Alzheimer disease 64 autoimmune diseases inflammatory 64 asthma COPD Chronic 64 Alzheimer disease cognitive impairment 63 cardio renal 63 macular degeneration ischemic 63 expanded autologous cellular 63 oncolytic virus therapies 63 blood coagulation disorders 63 cardiometabolic disorders 63 alfimeprase direct 63 novel immunotherapies 63 Combivir Kivexa 63 ocular diseases 63 P#X# antagonist 63 cognitive impairment associated 63 Friedreich Ataxia FRDA 63 neuropathic pain nerve 63 NTDDS 63 sodium thiosulfate STS 63 neuropathic pain spasticity 63 cardiovascular disorders 63 PDE# inhibitors 62 infectious diseases autoimmune diseases 62 HIV AIDS neuropathic pain 62 neurology immunology 62 liver cancers hypercholesterolemia 62 arthritis cardiovascular disease 62 commercializes innovative biopharmaceuticals 62 CNS gastrointestinal GI 62 ophthalmology dermatology 62 diseases fat malabsorption 62 dermatological diseases 62 dyslipidemia hypertension diabetes 62 recombinant biopharmaceutical 62 neuro inflammatory 62 Solazed TM 62 including eniluracil ADH 62 neuroscience autoimmune 62 neuro inflammatory disorders 62 hematologic diseases 62 inflammatory diseases 62 myasthenia gravis Huntington 62 epilepsy Parkinson disease 62 ELADUR ™ 62 cachexia anti infectives 62 REMOXY R 62 system dermatological GI 62 musculoskeletal diseases 62 NuMimetic TM 62 hypertension osteoarthritis 62 thrombotic disorders 62 immuno inflammatory 62 inflammation thrombosis oncology 62 investigational compounds 61 multiple sclerosis rheumatoid arthritis 61 commercializing anti infective 61 Prodarsan R 61 targeted immunotherapies 61 inflammation autoimmune diseases 61 respiratory allergy dermatological 61 R Saizen R 61 Revimmune TM 61 oncology urology 61 macular degeneration diabetic retinopathy 61 ALN PCS 61 vascular disorders 61 Alzheimer disease frontotemporal dementia 61 gastrointestinal disorders 61 epilepsy multiple sclerosis 61 stage hypoxia activated 61 glucokinase activator 61 Adnectin 61 pralatrexate injection folate analogue 61 ophthalmic diseases 61 neovascular diseases 61 oncology virology 61 romazarit 61 Fibromyalgia Syndrome FMS 61 metabolic diseases 61 Functional Somatic Syndromes 61 Obstructive Pulmonary Disease 61 products MKC# PP 61 COPD asthma 61 CB2 selective 61 cardiovascular anti infectives 60 peptide peptide mimetic 60 lupus multiple sclerosis 60 include neurology gastrointestinal 60 Selective Electrochemical Tumor Ablation 60 GERD migraine headaches 60 Parkinson disease epilepsy 60 Systemic RNAi TM 60 Nasdaq PARD biopharmaceutical 60 Nasdaq LXRX biopharmaceutical 60 delta gamma agonist 60 Syndrome RLS 60 PDE4 modulators 60 Nasdaq IMMU biopharmaceutical 60 HPV cervical dysplasia 60 NYSE Amex AEN 60 BioMarin develops 60 Brussels THR 60 anti infectives analgesics 60 oncology neurology 60 neurology autoimmune diseases 60 vaccines oncolytic virus 60 autoimmune uveitis 60 GI motility disorders 60 delivery polymer matrix 60 degenerative disorders 60 novel anti infective 60 hereditary emphysema 60 proprietary biomaterials 60 cosmetic cosmeceutical products 60 diseases bone metastasis 60 NASDAQ SNTA biopharmaceutical 60 neurology dermatology 60 Initiates Clinical Trial 60 MKC# MT 60 atrial fibrillation cardiovascular 60 CYT# potent vascular disrupting 60 rheumatoid arthritis gout 60 RECOTHROM ® 60 commercializing interventional 60 post herpetic neuralgia PHN 60 Genasense evaluating 60 disorders infectious diseases 60 system dermatological gastrointestinal 60 THR beta agonist 60 acetonide FA 60 OTCBB NRGX biotechnology 60 asthma allergic rhinitis 60 dermatology therapies 60 hypoxia activated prodrug 60 trodusquemine MSI 60 injury ischemic spastic 60 AKIP ™ 60 diabetes irritable bowel 60 candidates Azedra TM 60 skeletal sarcomere activators 60 tiapamil 60 neurovascular diseases 60 cardiovascular disease neurodegenerative diseases 60 psoriasis Crohn disease 59 topically delivered 59 tizanidine hydrochloride short 59 gastrointestinal disorders characterized 59 antiangiogenesis therapies 59 proprietary MSCRAMM protein 59 Alzheimer disease epilepsy 59 rheumatoid arthritis psoriatic arthritis 59 diarrhea predominant irritable 59 vaginally administered lidocaine 59 developing Surfactant Replacement 59 infectious diseases autoimmune 59 cardiac muscle contractility 59 PORxin TM platforms 59 Evoltra ® 59 POSIDUR ™ 59 HepDirect R 59 Ampakine compounds 59 Cytogen marketed 59 Liprotamase 59 squalamine 59 EVIZON TM squalamine lactate 59 Therapies SRT 59 Nasdaq HALO biopharmaceutical 59 proliferative diseases 59 polyneuropathy HIV DSP 59 prokinetic agent 59 gastrointestinal mucositis 59 Asthma COPD 59 rheumatoid arthritis inflammatory bowel 59 Innovive Pharmaceuticals 59 Surfactant Replacement Therapies SRT 59 degenerative neurological diseases 59 autotransfusion systems 59 Zemiva TM 59 neuropsychiatric diseases 59 QUADRAMET R 59 syndrome overactive bladder 59 Crofelemer budesonide foam 59 investigational therapies 59 FOLOTYN ® 59 diabetes hyperlipidemia 59 TÎ ² 4 59 synthetic cannabinoid compounds 59 ocular infections 59 Peyronie disease Frozen Shoulder 59 personalized cellular immunotherapy 59 rheumatoid arthritis psoriasis Crohn 59 R sorafenib tablets 59 lipid disorders 59 hematological disorders 59 fibrosis oncology 59 Veronate R 59 constipation OIC 59 Tß4 59 anti infective treatments 59 investigational monoclonal antibody 59 novel antibody therapeutics 59 Bioaccelerate compounds under 59 CDAD Clostridium difficile 59 topical anti infective 59 selective androgen receptor modulators 59 Frozen Shoulder Syndrome 59 Crohn disease rheumatoid arthritis 59 Supernus Pharmaceuticals 59 thetreatment 59 osteolytic bone disease 59 neuropathic pain 59 ischemic diseases 59 RNAi therapeutic targeting 59 retinal disorders 59 treat musculoskeletal metabolic 59 peptide therapeutics 59 non alcoholic steatohepatitis 59 rxRNA 58 CCR9 antagonist 58 coagulation disorders 58 psoriasis psoriatic arthritis 58 TRANSDUR ® 58 neuronal nicotinic receptors NNRs 58 postherpetic neuralgia PHN painful 58 immunology disorders 58 osteoarthritis rheumatoid arthritis 58 Multiple Sclerosis Rheumatoid Arthritis 58 Ostabolin C TM 58 diagnostic molecular imaging 58 small molecule therapeutics 58 Inc. Nasdaq NLTX 58 rheumatoid arthritis Crohn disease 58 use neuroblocking technology 58 Alzheimer disease Parkinson disease 58 commercializing novel biotherapeutics 58 anticancer antiviral 58 enhanced pharmacologic 58 hypertension pulmonary arterial 58 novel therapeutic antibodies 58 TTR amyloidosis 58 cardiopulmonary disorders 58 Boehringer Ingelheim MedImmune 58 immunology oncology 58 NNR Therapeutics 58 TRANSDUR ™ 58 investigating Serdaxin 58 immunoregulation 58 LUNESTA ® 58 monoclonal antibody therapeutics 58 Nasdaq MNKD focused 58 rheumatoid arthritis juvenile idiopathic 58 INS# [001] 58 topical anti infectives 58 Delta opioid receptor 58 areas neurology gastrointestinal 58 Davunetide 58 Synavive ™ 58 muscarinic receptor agonist 58 vitreoretinal disorders 58 diabetic retinopathy hyphema glaucoma 58 Zorbtive TM 58 cardiovascular metabolic diseases 58 Levulan ® PDT 58 retinal vein occlusion induced 58 oxypurinol 58 cardiometabolic 58 Systemic lupus erythematosus SLE 58 inflammatory cardio metabolic 58 cardiopulmonary bypass extracorporeal circulation 58 nitric oxide donating 58 norepinephrine reuptake inhibitor 58 liver cancers TTR 58 OTCBB IMNR 58 ERYtech 58 CB2 receptor selective 58 cerebro cardiovascular diseases 58 gastroenterology respiratory 58 oncologic diseases 58 please visit http:/www.vandapharma.com 58 immunological disorders 58 multiple sclerosis Crohn disease 58 ankylosing spondylitis psoriatic arthritis 58 MEDA AB publ 58 XIAFLEX ® 58 nalbuphine ER 58 Rhucin ® recombinant 58 Archexin 58 either acutely decompensated 58 cutaneous lupus 58 oncology anti infective 58 synthetic retinoid 58 catheter occlusion 58 osteoporosis arthritis 58 mitotic kinesins family 58 tubulin inhibitor 58 syndrome gastroesophageal reflux 58 Detrol Detrol LA 58 vascular occlusive diseases 58 Pharma Merck Serono 58 Inc. NASDAQ AGIX 58 Disease IBD 58 gastroenterology orthopedics 58 infectious autoimmune 58 endocrinology gastroenterology 58 SinuNase ™ 58 molecular chaperone regulation 58 commercializes diversified 58 orthopedics spine 57 dermatologic diseases 57 R MSCRAMM 57 mediated amyloidosis ATTR hypercholesterolemia 57 product platforms AZX# 57 CNS hemorrhage 57 Nasdaq NRGN 57 Cardiovascular Diabetes 57 XL# anticancer compounds 57 spinal stenosis degenerative disc 57 menopause contraception 57 Ception Therapeutics 57 sapacitabine CYC# 57 thrombotic diseases 57 CD# CEA 57 targeting Inflammatory Bowel 57 Ischemic Spastic Paraplegia Traumatic 57 gastrointestinal infectious 57 common neurovascular complication 57 Xcytrin R 57 OTCBB URGP specialty 57 treat gastrointestinal disorders 57 palonosetron hydrochloride Injection Dacogen 57 TELINTRA 57 NNRs 57 include ClindaReach TM 57 targeted radiotherapeutics 57 macular degeneration glaucoma 57 M# rationally 57 oncology dermatology 57 Nasdaq ONXX 57 diabetes cardiovascular disease 57 Oncology Primary Care 57 Kosan dependence 57 atopic dermatitis neonatal 57 deCODE Glaucoma TM 57 myelofibrosis polycythemia vera 57 Morria Biopharmaceuticals Plc 57 immunosuppression specifically 57 HCV protease inhibitors 57 external counterpulsation systems 57 enhanced skin permeation 57 intracellular signaling pathways 57 rheumatoid arthritis lupus 57 metabolic disorders 57 cardiac muscle myosin 57 ® bortezomib 57 acne impetigo 57 ionotropic glutamate receptor antagonists 57 Savella ® 57 immunotherapeutic approaches 57 transthyretin mediated amyloidosis ATTR 57 Syndax Pharmaceuticals Inc. 57 Sudhir Agrawal D.Phil 57 LHRH antagonists 57 regenerative therapeutics 57 AMEX REX 57 Ligand proprietary 57 TRAIL receptor antibodies 57 IMiDs 57 Genaera Corporation 57 AzaSite TM 57 oral JAK#/JAK# inhibitor 57 peptibody 57 Panzem R 57 mGluR4 PAM 57 cystic fibrosis inflammation autoimmune 57 GABITRIL 57 progressive neurodegenerative 57 adrenergic regulation 57 orthobiologic 57 New Chemical Entities 57 chronic thromboembolic pulmonary 57 immunotherapeutics 57 surfactant therapies 57 Ketotransdel TM 57 cardio cerebral vascular 57 small molecule thrombopoietin 57 investigational humanized monoclonal antibody 57 Atrigel 57 NASDAQ ABII 57 Bifunctional Muscarinic Antagonist Beta2 57 neuromuscular spasm 57 acne psoriasis 57 pharmaceuticals nutritionals 57 hypercholesterolemia liver 57 Parkinson disease multiple sclerosis 57 milnacipran HCl 57 Initiates Enrollment 57 Oral NKTR 57 STRIANT ® testosterone buccal 57 Immunotherapeutic 57 Behcet uveitis 57 EVIZON TM 57 Cobalamin TM mediated 57 endocrine disorders 57 Optiquel ™ 57 antisense inhibitors 57 neurodegenerative diseases 57 tPA antithrombotics anticoagulation therapy 57 anthrax botulism typhoid 57 glaucoma ischemia 57 ALN RSV program 57 LymphoStat B belimumab 57 anticancer therapeutics 57 markets HP Acthar 57 Agonist MABA program 57 post herpetic 57 NASDAQ BTRX pharmaceutical 57 inherited retinal 57 Modrenal R 57 MTP inhibitor 57 biased ligand 57 ophthalmology dermatology cardiovascular disease 57 HeFH 57 advancing novel biotherapeutics 57 EGFR HER 57 fusion enhancers 57 orally bioavailable mimics 57 neuro degenerative diseases 57 EnVivo Pharmaceuticals 57 Agios Pharmaceuticals 57 Nasdaq IDRA 57 anesthetic analgesic 57 StromaCel Inc. 57 psoriasis inflammatory bowel 57 pacemakers implantable cardioverter defibrillatorsHELB 57 Inc. NASDAQ AEZS 57 including thyroiditis RA 57 migraines neurorehabilitation 57 Ceragenin ™ 57 subsidiaries visit http:/www.apricusbio.com 57 protein kinase inhibitors 57 cardiovascular disease thrombosis oncology 57 lintuzumab SGN 57 secondary hyperparathyroidism 57 OTCBB NVLT biopharmaceutical 57 immuno pharmaceutical 56 AAG geldanamycin analog 56 ALN HTT 56 cardiometabolic diseases 56 multiple sclerosis psoriasis 56 Homspera TM 56 cardiology nephrology 56 urology gastroenterology 56 XP# XP# 56 neurodegenerative diseases autoimmune diseases 56 drug metabolism bioavailability 56 ophthalmologic disorders 56 nucleoside tide 56 GED aPC 56 inherited metabolic disorders 56 Vitrasert ® 56 inflammation hemophilia oncology 56 dermatological indications 56 ZFP Therapeutics 56 OTCBB ARGA specialty 56 Entereg R 56 neurological diseases 56 Cetrorelix 56 CRMD pharmaceutical 56 Cardiovascular Metabolic 56 Budesonide foam crofelemer 56 AGGRASTAT R tirofiban hydrochloride 56 HuLuc# 56 treatmentof 56 Inc. OTCBB LPTN 56 Oracea TM 56 Therapeutic Competitors Companies 56 endocrine metabolic 56 depression schizophrenia bipolar 56 4SC AG ISIN DE# 56 oral ghrelin agonist 56 Nanobody ® 56 CNS hematology oncology 56 equine osteoarthritis 56 oncology neuroscience 56 rheumatoid arthritis osteoarthritis ankylosing 56 cystic fibrosis chronic pancreatitis 56 systemic autoimmune 56 neurotology neuropsychology headaches 56 samarium Sm 56 therapeutic peptide 56 dermatology gastroenterology 56 fatty acid amide hydrolase 56 molecular imaging radiopharmaceutical 56 Luveris R Ovidrel R 56 Tissue Repair Company 56 cardiology oncology 56 AFREZZA TM 56 Exelixis compounds 56 novel therapeutics 56 Zemiva ™ 56 Regado Biosciences 56 patented Bioral 56 Intarcia 56 rusalatide acetate 56 oncology gastroenterology 56 prematurity Stargardt disease 56 Alvine Pharmaceuticals 56 epilepsy neuropathic pain 56 polymer conjugate technology 56 Nasdaq IDIX biopharmaceutical 56 proprietary intravenous formulation 56 adenosine A2A 56 targeted anticancer biopharmaceuticals 56 Naglazyme R 56 skeletal muscle contractility 56 Symphony tCGM 56 EHT AGN 56 neurodegenerative diseases oncology 56 MediGene focuses 56 Avonex interferon beta 1a 56 rheumatic diseases 56 telomerase therapeutic 56 JAK inhibitor 56 Squalamine 56 aldehyde dehydrogenase ALDH2 deficiency 56 Personalized Immunotherapy 56 dermatologic disorders 56 GVAX ® 56 formerly LymphoStat B 56 syndrome carcinoid syndrome 56 neovascular form 56 histone methyltransferases HMTs 56 small molecule agonists 56 Postherpetic neuralgia PHN 56 Predictive medicine 56 IV Busulfex 56 topical dermatology 56 novel peptide therapeutics 56 SIADH 56 cancer indications bafetinib 56 nociceptive pain 56 functional genomics proteomics 56 subsidiaries Laboratorios Belmac Laboratorios 56 candidate CRLX# 56 Ceflatonin R 56 muscarinic receptor agonists 56 lymphomas leukemias 56 orthopedics oncology 56 Inc. NASDAQ SNUS 56 Zenvia ™ 56 Corporation Nasdaq CRGN 56 sells Osteocel R 56 targeted radiotherapeutic 56 serine protease inhibitor CU# 56 addressing idiopathic pulmonary 56 inflammatory demyelinating 56 Photodynamic Therapy PDT 56 Multiple sclerosis MS 56 GW# [003] 56 molecular biology genomics 56 severe malignant osteopetrosis 56 cardiovascular cerebrovascular 56 refractory gout 56 Metabolic Disease 56 neurodegenerative disorders 56 therapeutic modalities 56 lexidronam injection 56 erythematosus 56 systemic juvenile idiopathic 56 insomnia migraine headaches 56 isoform selective 56 muscular dystrophy cystic fibrosis 56 Nanobody R 56 treat dysmenorrhea 56 Logical Therapeutics 56 TM Aganocide 56 AMD diabetic retinopathy 56 pediatric Crohn disease 56 INxin TM 56 vaccine GRNVAC1 56 PI3K/Akt pathway inhibitor 56 commercializing novel 56 Hervé Hoppenot President 56 Adamis Viral Therapies 56 hematological indications 56 Selzentry Celsentri 56 TOPIGEN 56 AzaSite Xtra 56 NP2 Enkephalin 56 ASONEP TM 56 proliferator activated receptor 56 systemic fungal infections 56 transthyretin TTR mediated amyloidosis 56 molecular imaging radiopharmaceuticals 56 nephrology oncology supportive 56 benign prostatic hypertrophy BPH 56 intranasal insulin product 56 treat chronic sinusitis 56 derivatives Radilex TM 56 MAXY VII 56 synthetic nucleic acid 56 Factor VIIa 56 Initiates Dosing 56 cardiology gastroenterology 56 Ph.D. Targacept 56 Epoetin alfa therapy 56 commercialize becocalcidiol patented 56 Campath ® 56 immuno modulatory 56 resorbable biomaterials 56 severe gastroparesis 56 Aganocide 56 TRIOLEX HE# APOPTONE HE# 56 autologous cellular therapy 56 endocrine abnormalities 56 inflammation transplantation hemophilia 56 neurosurgery urology 56 dermatology urology 56 atherosclerosis hypertension 56 BENLYSTA ® 56 please visit www.medicinova.com 56 Noven Therapeutics Noven 56 psychiatry neurology 56 novel RNAi therapeutics 56 cardiovascular thrombosis oncology 56 Mesafem 56 vaginal candidiasis 56 candidate XP# 56 GM DUSA dermatology 56 HepDirect 56 Microplasmin 56 Posiphen TM 56 lipohypertrophy 56 INTEGRILIN R eptifibatide Injection 56 Nasdaq ENMD 56 nicotinic alpha 7 56 Inc. dba Vitro 56 INHIU 56 5 HT6 receptor 56 endocrinology orthopedics kidney 56 SYN# 56 delta opioid receptor 56 Rheumatoid Arthritis RA 56 Salmedix 56 www.ucb group.com 56 Azmacort R 56 cerebro cardiovascular disease 56 Elagolix 56 myeloproliferative neoplasms 56 microRNA therapeutics 56 TRIOLEX HE# 56 malignant infectious 56 sirtuin inhibitor program 55 antiphospholipid syndrome APS 55 gastrointestinal disorders ATI 55 Announces Poster Presentations 55 NYSE Amex PTN 55 Alessandro Riva 55 multiple sclerosis amyotrophic lateral 55 YM AIM YMBA 55 VNS Therapy TM 55 neuroblocking technology 55 Receives Orphan Drug 55 manufactures minimally invasive 55 Inc. AMEX AEN 55 Verus Pharmaceuticals 55 using VIAdel TM 55 iSONEP TM 55 immune modulators 55 developing Bicifadine serotonin 55 ARRY # 55 Neutrolin ® 55 includes investigational compounds 55 endocrinology oncology 55 developing Surfactant Therapies 55 topical dermatological products 55 clinically validated targets 55 Pemphigus Vulgaris 55 pharmacological chaperone 55 Diabetic macular edema 55 candidate deforolimus 55 EVIZON ™ 55 Nasdaq MITI biopharmaceutical 55 AZD# TC 55 microsurgical disciplines 55 receptor VR1 antagonists 55 receptor tyrosine kinase inhibitor 55 DGAT1 inhibitors 55 Nerve Targeting Drug 55 primary Restless Legs 55 preclinical compounds 55 JAK inhibitors 55 targeting PCSK9 55 cardiovascular endocrine 55 Namenda Memantine HCl 55 anthrax tuberculosis typhoid 55 commercializes therapeutics 55 OTC BB PVCT 55 ENL recurrence 55 alpha interferons 55 interferon alpha IFN 55 validating biomarkers 55 MOVIPREP R 55 novel peptides 55 toenail onychomycosis 55 IMiDs ® 55 overactive bladder VANTAS R 55 hepatitis C viral infection 55 DG# compounds targeting 55 neuropathies 55 ocular inflammatory 55 Huntingtons disease 55 neurology infectious 55 ospemifene 55 Nasdaq PGNX 55 systemic lupus erythematosus lupus 55 psoriatic arthritis PsA 55 allergic rhinitis hay fever 55 Biomoda www.biomoda.com 55 Æterna Zentaris Inc. 55 Cholestagel 55 opioid bowel dysfunction 55 dysphagia esophagitis 55 markets Testim ® 55 davunetide intravenous AL 55 NASH Huntington 55 Unit Dose Budesonide 55 Vascular Endothelial Growth 55 Pyridorin 55 photodisinfection 55 vascular abnormalities 55 small molecule 55 androgen receptor modulator 55 protein misfolding diseases 55 delivers fluocinolone acetonide FA 55 constipation predominant irritable bowel 55 Tramiprosate ALZHEMED TM 55 dextromethorphan quinidine 55 lucinactant 55 spinal stimulation 55 Cardium Therapeutics TM 55 Initiates Phase II 55 Bucindolol 55 t2cure GmbH 55 IMiDs R 55 Dupuytren Disease 55 Surfaxin LS 55 FACTIVE R gemifloxacin 55 RECOTHROM R 55 dihydrochloride Tablets 55 PDE4 inhibitor 55 Cellegy Pharmaceuticals 55 oral PTH 55 IMiDs ® compound 55 modified glutathione analog 55 neurological disorders 55 identify protein biomarkers 55 staphylococcal vaccines 55 includes introducers guidewires 55 Rebif interferon beta 1a 55 Cerimon 55 humanized therapeutic 55 Namenda ® 55 injectable antithrombotics 55 formed Alnylam Biotherapeutics 55 systemic RNA interference 55 PLX MS 55 p# inhibitor 55 Hedgehog antagonist 55 Nanobody 55 Submits Response 55 non personalized allogeneic 55 Med eMonitor System 55 vitreous floaters 55 technology visit http:/www.genmab.com 55 including acne photodamage 55 R PEG uricase 55 Inc. Nasdaq CRTX 55 ophthalmological diseases 55 pruritus rash 55 Staphylococcus aureus Immune Globulin 55 TLR antagonists 55 Nasdaq GENR 55 TRACON Pharmaceuticals 55 oncology therapeutics 55 nasopharyngitis headache 55 Novogyne joint venture 55 Nasdaq RXII 55 APT Pharmaceuticals 55 NAGS deficiency 55 Sylvie Gregoire President 55 ATG Fresenius S 55 Enkephalin 55 subsidiaries InnerCool Therapies 55 Retisert ® 55 arthroscopy powered 55 pentadentate logo R 55 Resurgex Plus R 55 DVT prophylaxis cholesterol 55 ArQule Kinase Inhibitor Platform 55 renin inhibition promising 55 cryosurgical treatment 55 musculoskeletal metabolic 55 Inc. Nasdaq LXRX 55 Adherex Technologies Inc. 55 OTCBB PYTO 55 antibacterial therapeutics 55 Inc. AMEX YMI 55 NovaDel oral spray 55 urological disorders 55 Pimavanserin 55 Begins Dosing 55 HuMax TAC 55 www.sorin.com 55 Celsion Corporation 55 Inc. NASDAQ TRGT 55 behavioral neurobiology 55 hematopoietic malignancies 55 Cephalon GlaxoSmithKline 55 Dengue hemorrhagic fever DHF 55 XP #L 55 Eg5 kinesin spindle 55 lupus nephritis 55 Lixivaptan 55 Neurodegenerative diseases 55 Cx# [002] 55 include Altastaph TM 55 cardiovascular disease osteoporosis 55 fibrotic disease 55 Aganocide ® 55 developing chemokine 55 gastro intestinal disorders 55 insomnia sleep apnea 55 beta secretase inhibitors 55 Arno Therapeutics 55 Merck OSI Pharmaceuticals 55 anticoagulant reversing agent 55 please visit www.dyax.com 55 pharmacogenomic tests 55 beta blockers ACE inhibitors 55 HepeX B 55 selective angiogenic kinase inhibitor 55 endothelin antagonist 55 systemic lupus erythematosus psoriasis 55 nephrology urology 55 abnormal angiogenesis 55 ophthalmic therapeutics 55 ADP receptor antagonist 55 cardio metabolic disease 55 leukotriene pathway 55 staphylococcal vaccine 55 superior ophthalmologic products 55 lexidronam injection PROSTASCINT 55 Syntonix 55 oncology 55 Frozen Shoulder syndrome 55 transmucosal delivery 55 chronic myocardial ischemia 55 http:/www.unigene.com 55 LPM TM 55 idiopathic thrombocytopenic purpura ITP 55 Oxis International 55 sanofi aventis Bayer Schering 55 cardiovascular neuroscience 55 highly selective inhibitor 55 tranilast 55 debilitating autoimmune 55 ZaBeCor 55 neurodegenerative 55 enhance ApoA 55 NexVas TM 55 RNAi therapeutic 55 ophthalmology orthopedics 55 hypertension dyslipidemia 55 venous stasis ulcers 55 GPR# agonist 55 MKC# MKC# PP 55 eye vitreous hemorrhage 55 Major Depressive Disorder MDD 55 NovaBay Aganocide compounds 55 Ibis T# TM 55 Xyfid TM 55 commercialize ZYFLO CR 55 ZARS Pharma 55 constipation IBS C 54 QuatRx 54 non cirrhotic portal 54 chemotherapy induced neutropenia 54 ZFNs clinical trials 54 Symadex 54 albiglutide currently 54 fibrosis IPF 54 proprietary dermal 54 XL# XL# 54 vascular endothelial dysfunction 54 induced macular edema 54 dermatology urology gynecology orthopedics 54 psoriasis eczema 54 Iluvien ® 54 MEK inhibitors 54 hematological diseases 54 allosteric modulator PAM 54 neutropenia thrombocytopenia 54 Thrombin topical Recombinant 54 Amex KAL 54 HDL Mimetic Peptide 54 Licenses Novel 54 visit http:/www.mannkindcorp.com 54 commercializing aptamer therapeutics 54 anthrax botulism tuberculosis typhoid 54 OTCBB NPHC biotechnology 54 mGluR2 NAM 54 proprietary capillary aerosolization 54 including Random Activation 54 anti infective therapeutic 54 novel VDA molecule 54 www.ucb.com 54 2A receptor agonist 54 CYCLOSET ® 54 Trofex TM 54 Central Nervous System 54 gastrointestinal genitourinary 54 treating neuropathic pain 54 surgical instruments electrosurgery 54 Tasimelteon 54 neoplastic diseases 54 gastrointestinal GI disorders 54 novel histone deacetylase 54 AA Amyloidosis 54 Corporation researches develops 54 MELAS 54 NYSE Amex NBY clinical 54 Nasdaq VNDA 54 levocetirizine 54 OSI Eyetech 54 Epiduo 54 ceroid lipofuscinosis NCL 54 glaucoma macular degeneration 54 retinal vein occlusion RVO 54 CTLA4 Ig 54 PKU genetic 54 melanocortin 54 microplasmin Phase III 54 Adenosine Therapeutics 54 Injury ALI 54 nephrology oncology 54 punctal plug delivery 54 myeloproliferative diseases 54 oral Janus kinase 54 thrombotic disorders malignant neoplasm 54 Generx TM 54 Mipomersen 54 induced mucositis 54 Baxa customer 54 delay bone metastases 54 debilitating complication